Action
BCR-ABL, Src, Multiple Tyrosine kinases targeted
Alt Name
Sprycel
Dasanix
Approval Jurisdiction
2006 FDA, EMA
Approved for clinical use
Chronic Myelogenous Leukemia, ALL
Brutto
C22H26ClN7O2S
CAS
302962-49-8
Commercial Vendor
BMS
Compound Image
Dasatinib.png
Compound name
Dasatinib
InChI
InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)
InChI Key
ZBNZXTGUTAYRHI-UHFFFAOYSA-N
MW
487.00
Patent
<a href="http://www.wipo.int/patentscope/search/en/result.jsf?query=ALLNUM%3AWO2009094556">WO2009094556</a>
PubChem CID
3062316
Reference 2
SMILES
CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCOCopy
Approved Drug List
1